Trusted Resources: Education
Scientific literature and patient education texts
Ethical Perspectives on Treatment Options With Spinal Muscular Atrophy Patients
source: Annals of neurology
year: 2022
authors: Yeo CJJ,Simmons Z,De Vivo DC,Darras BT
summary/abstract:Since 2016, three innovative therapies for spinal muscular atrophy have changed the face of disease. Although these therapies often result in remarkable improvements in infants and children, benefits in adults are modest and treatment is not curative. Concerns have been raised about the enormous costs of these medications, the ultimate burden to taxpayers, and the costs to society of withholding treatments and sacrificing or disadvantaging some individuals. Physicians are best positioned to serve our patients by carefully considering the costs, benefits, implications for quality of life, and the interplay of these factors within the framework of core ethical principles that guide clinical care. This article is protected by copyright. All rights reserved.
organization: Boston Children's Hospital, Harvard Medical School, Boston, MA, USA.DOI: 10.1002/ana.26299
read more
Related Content
-
Intrathecal Administration of Nusinersen Using the Ommaya Reservoir in an Adult With 5q-Related Spinal Muscular Atro...Spinal muscular atrophy (SMA) is a hered...
-
A ‘Miracle’: Spinraza Gives Boy, Now 5, a Chance to Grow UpIt’s now been more than four years sin...
-
Pediatric Spinal Muscular AtrophyWhat is spinal muscular atrophy (SMA)?Sp...
-
Spine Surgery Effective in SMA Type 1 Children, But Not Without RisksSurgery to correct kyphoscoliosis — a ...
-
Why Some Drugs Cost $2.1 Million per Dose and how one Company Plans to Change ThisWith a cost of $2.1 million for a one-do...
-
Despite Taking Spinraza, SMA Type 1 Children Show Nonmotor ProblemsDespite its well-reported benefits in mo...
-
FDA-Approved Treatment Provides Life-Saving Miracle for Girl With Spinal Muscular AtrophyAlex says her daughter made it to Norton...